We think the stake in wide-moat Sartorius contributes to Bio-Rad’s moat. Although Bio-Rad does not have a controlling stake, Sartorius accounts for approximately 40% of Bio-Rad’s fair value in our ...

HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of ...

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

Dr. Ferrara will lead clinical strategy, advancing solutions that improve patient outcomes and support the company’s AI-powered Healthcare from the Eye initiative.

DiMe assistant programme director Candice Taguibao said: "We greatly appreciate the level of engagement and support from the ...

Introduction Interstitial lung disease (ILD) patients may develop a progressive phenotype usually characterised by ...

A new study reveals "serious adverse events" associated with mifepristone, commonly called the "abortion pill," as ...

A pivotal trial of an electronic artificial urinary sphincter could herald the future of treating incontinence.

A global research team has discovered a breakthrough set of urine biomarkers for prostate cancer that outperform the ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

A newly published study indicates that prostate cancer can be diagnosed at an early stage through a simple urine sample. With the aid of AI and extensive analyses of gene activity in tumors, they have ...